Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Malignant Musculoskeletal Neoplasm: early-phase trial registry

1 of 2 indexed Malignant Musculoskeletal Neoplasm trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Malignant Musculoskeletal Neoplasm: 2 US clinical trials tracked, 1 recruiting.

Malignant Musculoskeletal Neoplasm is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 2 of these trials.

Enrollment posture brief

Registry condition malignant-musculoskeletal-neoplasm

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Malignant Musculoskeleta (th…50%
Open-enrollment share among volume-matched conditions near Malignant Musculoskeletal Neoplasm

Malignant Musculoskeletal Neoplasm lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Malignant Musculoskeletal Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Malignant Musculoskeletal Neoplasm is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Mayo Clinic 2 trials

Named interventions

Most-linked intervention names on Malignant Musculoskeletal Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Genetic Testing Other
2 trials
Biospecimen Collection Procedure
2 trials
Genetic Counseling Other
1 trials
Survey Administration Other
1 trials

US sites by state

Facility locations filed on Malignant Musculoskeletal Neoplasm trials. A trial with sites in several states counts in each.

Florida 2 trials
Arizona 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Malignant Musculoskeletal Neoplasm page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Malignant Musculoskeletal Neoplasm trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Malignant Musculoskeletal Neoplasm trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Malignant Musculoskeletal Neoplasm condition card totals 2 registered trials; most-linked intervention Genetic Testing; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.